Lenskart Solutions Limited (NSE:LENSKART)
India · Delayed Price · Currency is INR 654.80
+15.20 (2.38%)
At close: Aug 20, 2026
Lenskart Solutions Revenue
Lenskart Solutions had revenue of 27.14B INR in the quarter ending June 30, 2026, with 43.27% growth. This brings the company's revenue in the last twelve months to 96.34B, up 37.10% year-over-year. In the fiscal year ending March 31, 2026, Lenskart Solutions had annual revenue of 88.14B with 32.49% growth.
Revenue (ttm)
96.34B
Revenue Growth
+37.10%
P/S Ratio
11.82
Revenue / Employee
5.02M
Employees
19,201
Market Cap
1.14T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 88.14B | 21.62B | 32.49% |
| Mar 31, 2025 | 66.53B | 12.25B | 22.57% |
| Mar 31, 2024 | 54.28B | 16.38B | 43.23% |
| Mar 31, 2023 | 37.89B | 22.87B | 152.17% |
| Mar 31, 2022 | 15.03B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 599.11B |
| Aurobindo Pharma | 349.35B |
| Zydus Lifesciences | 285.92B |
| Cipla | 280.68B |
| Apollo Hospitals Enterprise | 264.30B |
| Biocon | 173.21B |
| Mankind Pharma | 147.38B |
| Divi's Laboratories | 112.30B |
Lenskart Solutions News
- 8 days ago - Lenskart Solutions Transcript: Q1 26/27 - Transcripts
- 8 days ago - Lenskart Solutions Quarterly report: Q1 2027 - Filings
- 8 days ago - Lenskart Solutions Shareholder letter: Q1 2027 - Filings
- 3 months ago - Lenskart Solutions Transcript: Q4 25/26 - Transcripts
- 3 months ago - Lenskart Solutions Quarterly report: Q4 2026 - Filings
- 3 months ago - Lenskart Solutions Annual report: Q4 2026 - Filings
- 6 months ago - Lenskart Solutions Transcript: Q3 25/26 - Transcripts
- 6 months ago - Lenskart Solutions Shareholder letter: Q3 2026 - Filings